Neurocrine Biosciences (NBIX) Interest Expenses (2017 - 2024)

Neurocrine Biosciences has reported Interest Expenses for 8 years, with the latest figure at $1.1 million in Q1 2024.

• For the quarter ending Q1 2024, Interest Expenses changed 0.0% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2024 stood at $1.1 million (down 76.09% YoY), and the FY2023 full-year result was $4.6 million, down 35.21% from the prior year.
• Interest Expenses for Q1 2024 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
• The five-year high for Interest Expenses was $8.5 million in Q3 2020, with the low at $1.1 million in Q4 2022.
• Historically, Interest Expenses has averaged $4.2 million across 5 years, with a median of $2.6 million in 2022.
• Annual changes were most pronounced in 2020 — Interest Expenses increased 6.25% — and 2022, when it tumbled 83.33%.
• Neurocrine Biosciences' Interest Expenses stood at $7.8 million in 2020, then decreased by 15.38% to $6.6 million in 2021, then plunged by 83.33% to $1.1 million in 2022, then changed by 0.0% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024.
• The last three Interest Expenses figures came in at $1.1 million (Q1 2024), $1.1 million (Q4 2023), and $1.1 million (Q3 2023), per Business Quant data.